Denali Therapeutics Inc. Lessor, Operating Lease, Payment to be Received, Year Five
Denali Therapeutics Inc. (DNLI) had Lessor, Operating Lease, Payment to be Received, Year Five of $876.00 thousand as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Notes › Leases › Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity
us-gaap:LessorOperatingLeasePaymentsToBeReceivedFiveYears · last filed 2020-05-07
- 2020-03-31: Lessor, Operating Lease, Payment to be Received, Year Five $876.00K.
- 2019-12-31: Lessor, Operating Lease, Payment to be Received, Year Five $876.00K.
- 2019-09-30: Lessor, Operating Lease, Payment to be Received, Year Five $3.10M.
- 2019-06-30: Lessor, Operating Lease, Payment to be Received, Year Five $3.10M.
| Period end | Lessor, Operating Lease, Payment to be Received, Year Five |
|---|---|
| 2020-03-31 | $876.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $876.00K 10-K · filed 2020-02-27 |
| 2019-09-30 | $3.10M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $3.10M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $3.10M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |